Rize Oncology Inc. (CSE: RIZE)
Canada
· Delayed Price · Currency is CAD 0.100
0.00 (0.00%)
At close: Jan 17, 2025
Rize Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 0.97 | 1.36 | 1.8 | 0.18 | 0.05 | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 0.97 | 1.36 | 1.8 | 0.18 | 0.05 | 0.01 | Upgrade
|
| Cash Growth | -29.04% | -24.06% | 898.49% | 296.21% | 348.86% | -60.46% | Upgrade
|
| Prepaid Expenses | 0.05 | 0.05 | 0.15 | - | - | 0 | Upgrade
|
| Other Current Assets | - | - | - | 0.19 | - | 0 | Upgrade
|
| Total Current Assets | 1.02 | 1.41 | 1.94 | 0.37 | 0.05 | 0.01 | Upgrade
|
| Total Assets | 1.02 | 1.41 | 1.94 | 0.37 | 0.05 | 0.01 | Upgrade
|
| Accounts Payable | 0.03 | 0.03 | 0.06 | 0.21 | 0 | 0 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.12 | 0.02 | Upgrade
|
| Other Current Liabilities | - | 0.01 | 0.02 | - | - | - | Upgrade
|
| Total Current Liabilities | 0.03 | 0.04 | 0.09 | 0.21 | 0.12 | 0.02 | Upgrade
|
| Total Liabilities | 0.03 | 0.04 | 0.09 | 0.21 | 0.12 | 0.02 | Upgrade
|
| Common Stock | 4.2 | 4.2 | 4.18 | 1.25 | 0.16 | 0 | Upgrade
|
| Additional Paid-In Capital | 1.66 | 1.63 | 1.48 | 0.79 | - | 0.16 | Upgrade
|
| Retained Earnings | -4.66 | -4.28 | -3.59 | -1.88 | -0.24 | -0.17 | Upgrade
|
| Comprehensive Income & Other | -0.21 | -0.17 | -0.2 | - | -0 | - | Upgrade
|
| Shareholders' Equity | 0.99 | 1.37 | 1.86 | 0.16 | -0.08 | -0.01 | Upgrade
|
| Total Liabilities & Equity | 1.02 | 1.41 | 1.94 | 0.37 | 0.05 | 0.01 | Upgrade
|
| Total Debt | - | - | - | - | 0.12 | 0.02 | Upgrade
|
| Net Cash (Debt) | 0.97 | 1.36 | 1.8 | 0.18 | -0.08 | -0.01 | Upgrade
|
| Net Cash Growth | -29.04% | -24.06% | 898.49% | - | - | - | Upgrade
|
| Net Cash Per Share | 0.02 | 0.03 | 0.04 | 0.01 | -0.00 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 38.74 | 38.74 | 48.38 | 47.85 | 0.79 | 0.72 | Upgrade
|
| Total Common Shares Outstanding | 38.74 | 38.74 | 48.38 | 38.51 | 0.79 | 0.72 | Upgrade
|
| Working Capital | 0.99 | 1.37 | 1.86 | 0.16 | -0.08 | -0.01 | Upgrade
|
| Book Value Per Share | 0.03 | 0.04 | 0.04 | 0.00 | -0.10 | -0.01 | Upgrade
|
| Tangible Book Value | 0.99 | 1.37 | 1.86 | 0.16 | -0.08 | -0.01 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.04 | 0.04 | 0.00 | -0.10 | -0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.